二甲双胍通过PI3K/AKT/GSK3β信号通路对肺癌A549细胞增殖的影响

doi:10.13481/j.1671-587X.20210313

Abstract

Abstract: Objective

To investigate the effect of metformin on the proliferation of the non-small cell lung cancer A549 cells ，and to clarify its possible mechanism.

Methods

The A549 cells were divided into control group and different concentrations （1， 2， 4， 8， 16 and 32 mmol·L^－1） of metformin groups.MTT method was used to detect the proliferation rates of A549 cells in various groups after treated for 24， 48 and 72 h； clone formation experiment was used to detect the clone formation number of A549 cells in various groups； cell scratch test was used to detect the migration rates of A549 cells in various groups； RT-PCR method was used to detect the expression levels of phosphoinositide-3-kinase （PI3K）， protein kinase B （AKT）， and glycogen-synthase kinase-3β （GSK3β） mRNA in the A549 cells in various groups； Western blotting method was used to detect the expression levels of PI3K， PI3K（p-PI3K）， AKT， phosphorylated AKT（p-AKT）， GSK3β ，and phosphorylated GSK3β （p-GSK3β） proteins in the A549 cells in various groups.

Results

Compared with control group， the proliferation rates of lung cancer A549 cells in different concentrations of metformin groups after treated for 24， 48 and 72 h were decreased （P<0.05）； compared with control group， the number of clone formation in the A549 cells in 2 and 8 mmol·L^－1 metformin groups was decreased （P<0.05）； compared with control group， the migration rates of the A549 cells in 2 and 8 mmol·L^－1 metformin groups were decreased （P<0.05）； compared with control group， the expression levels of PI3K， AKT and GSK3β mRNA in the A549 cells in 2 and 8 mmol·L^－1 metformin groups were significantly decreased （P<0.05）； compared with control group， the expression levels of PI3K， p-PI3K， p-AKT， and p-GSK3β proteins in the A549 cells in 2 and 8 mmol·L^－1 metformin groups were significantly decreased （P<0.05）.

Conclusion

Metformin can inhibit the proliferation and migration of lung cancer A549 cells， and its mechanism may be related to the inhibition of PI3K/AKT/GSK3β signaling pathway.

Key words: lung cancer, metformin, proliferation, migration, PI3K/AKT/GSK3β signaling pathway

CLC Number:

R734.2

Chunqing MU, Lei ZHOU, Nan ZHAO, Hong WANG, Zhi LI. Effect of metformin on proliferation of lung cancer A549 cells through PI3K/AKT/GSK3β signaling pathway[J].Journal of Jilin University(Medicine Edition), 2021, 47(3): 637-643.

Figures/Tables 8

Tab. 1

Fig. 1

Fig. 2

Fig. 3

Fig. 4

Fig.5

Fig.6

Fig. 7

References

1	TORRE L A， SIEGEL R L， JEMAL A. Lung cancer statistics［J］. Adv Exp Med Biol， 2016， 893（2）： 1-19.
2	HIRSCH F R， SCAGLIOTTI G V， MULSHINE J L， et al. Lung cancer： current therapies and new targeted treatments［J］. Lancet， 2017， 389（10066）： 299-311.
3	章必成，朱波. 晚期非小细胞肺癌化学治疗的现状与未来［J］. 医药导报， 2018， 37（5）： 531-535.
4	DILMAN V M. Age-associated elevation of hypothalamic， threshold to feedback control， and its role in development， ageine， and disease［J］. Lancet， 1971， 1（7711）： 1211-1219.
5	ARRIETA O， VARELA-SANTOYO E， SOTO-PEREZ-DE-CELIS E， et al. Metformin use and its effect on survival in diabetic patients with advanced non-small cell lung cancer［J］. BMC Cancer， 2016， 16： 633.
6	YAO L， LIU M K， HUANG Y L， et al. Metformin use and lung cancer risk in diabetic patients： a systematic review and meta-analysis［J］. Dis Markers， 2019， 2019： 6230162.
7	CHUANG M C， YANG Y H， TSAI Y H， et al. Survival benefit associated with metformin use in inoperable non-small cell lung cancer patients with diabetes： a population-based retrospective cohort study［J］. PLoS One， 2018， 13（1）： e0191129.
8	YU C X， JIAO Y， XUE J， et al. Metformin sensitizes non-small cell lung cancer cells to an epigallocatechin-3-gallate （EGCG） treatment by suppressing the Nrf2/HO-1 signaling pathway［J］. Int J Biol Sci， 2017， 13（12）： 1560-1569.
9	谢建将，陈敏东，陈曲海，等. 二甲双胍对肺癌A549细胞增殖、迁移、侵袭能力及乳酸生成的影响［J］. 肿瘤学杂志， 2018， 24（4）： 323-327.
10	GUO Q Q， LIU Z Y， JIANG L L， et al. Metformin inhibits growth of human non-small cell lung cancer cells via liver kinase B-1-independent activation of adenosine monophosphate-activated protein kinase［J］. Mol Med Rep， 2016， 13（3）： 2590-2596.
11	ZHOU X H， LIU S S， LIN X M， et al. Metformin inhibit lung cancer cell growth and invasion in vitro as well as tumor formation in vivo partially by activating PP2A［J］. Med Sci Monit， 2019， 25： 836-846.
12	STOROZHUK Y， HOPMANS S N， SANLI T， et al. Metformin inhibits growth and enhances radiation response of non-small cell lung cancer （NSCLC） through ATM and AMPK［J］. Br J Cancer， 2013， 108（10）： 2021-2032.
13	LI L， WANG Y， PENG T， et al. Metformin restores crizotinib sensitivity in crizotinib-resistant human lung cancer cells through inhibition of IGF1-R signaling pathway［J］. Oncotarget， 2016， 7（23）： 34442-34452.
14	LUO Z， ZHU T， LUO W， et al. Metformin induces apoptotic cytotoxicity depending on AMPK/PKA/GSK-3β-mediated c-FLIP_L degradation in non-small cell lung cancer［J］. Cancer Manag Res， 2019， 11： 681-689.
15	AHMAD S， KHAN M Y， RAFI Z， et al. Oxidation， glycation and glycoxidation-The vicious cycle and lung cancer［J］. Semin Cancer Biol， 2018， 49： 29-36.
16	杜雯雯,黄建安.基于程序性死亡受体-1及其配体为靶点的肺癌免疫治疗新进展[J].中国实用内科杂志,2019,39(5):403-406.
17	DECENSI A， PUNTONI M， GOODWIN P， et al. Metformin and cancer risk in diabetic patients： a systematic review and meta-analysis［J］. Cancer Prev Res （Phila）， 2010， 3（11）： 1451-1461.
18	MALLIK R， CHOWDHURY T A. Metformin in cancer［J］. Diabetes Res Clin Pract， 2018， 143： 409-419.
19	李瑞阳，林芷伊，李晶，等. 化疗联合二甲双胍治疗前后非小细胞肺癌患者外周血中IGF-1和mTOR表达变化及其疗效分析［J］. 吉林大学学报（医学版）， 2020， 46（1）： 108-115.
20	RADENKOVIC S， KONJEVIC G， JURISIC V， et al. Values of MMP-2 and MMP-9 in tumor tissue of basal-like breast cancer patients［J］. Cell Biochem Biophys， 2014， 68（1）： 143-152.
21	DONG J Y， PENG H， YANG X L， et al. Metformin mediated microRNA-7 upregulation inhibits growth， migration， and invasion of non-small cell lung cancer A549 cells［J］. Anticancer Drugs， 2020， 31（4）： 345-352.
22	QIU M， XUE C Y， ZHANG L Y. Piperine alkaloid induces anticancer and apoptotic effects in cisplatin resistant ovarian carcinoma by inducing G2/M phase cell cycle arrest， caspase activation and inhibition of cell migration and PI3K/Akt/GSK3β signalling pathway［J］. J BUON， 2019， 24（6）： 2316-2321.
23	FU Q F， HUANG Y H， GE C L， et al. SHIP₁ inhibits cell growth， migration， and invasion in non?small cell lung cancer through the PI3K/AKT pathway［J］. Oncol Rep， 2019， 41（4）： 2337-2350.
24	ZHANG L， LIU B H. Sapylin inhibits lung cancer cell proliferation and promotes apoptosis by attenuating PI3K/AKT signaling［J］.J Cell Biochem，2019，120（9）： 14679-14687.
25	吴爱兵，黎明春，麦宗炯，等. CK2α通过PI3K/Akt/GSK-3β信号通路调控肺腺癌A549细胞的侵袭及迁移［J］. 中国肺癌杂志， 2017， 20（4）： 233-238.
26	刘少鹏，张琪，张红梅，等. 二甲双胍对人结肠癌HT29细胞的抑制作用及可能机制［J］. 福建医科大学学报， 2018， 52（1）： 7-11.

Group		Proliferation rate of A549 cells
Group	（t/d） 24		48	72
Control		100.00±0.00	100.00±0.00	100.00±0.00
Metformin (mmol·L^－1)
1		96.95±1.88^*	91.09±0.41^*	91.54±4.25^*
2		91.80±1.23^*	87.87±3.46^*	81.91±1.00^*
4		87.01±8.19^*	84.13±1.06^*	76.24±0.22^*
8		84.46±1.61^*	74.79±0.41^*	60.32±2.98^*
16		81.90±6.79^*	67.20±2.00^*	52.99±2.13^*
32		79.60±1.37^*	57.04±3.77^*	22.68±0.30^*

[1]	Runhong MU, Xinzhu LIU, Rui LIN, Yupeng LI, Luyao WANG, Chunyu WANG, Xiao GUO. Effect of PRDX6 over-expression of proliferation, invasion and migration of liver cancer cells and its molecular mechanism [J]. Journal of Jilin University(Medicine Edition), 2021, 47(3): 559-565.
[2]	Cuilan LIU, Jianjun LI, He JIANG, Jing LIU, Dan WANG, Chen LI, Di ZHAO. Effect of urolithin B on biological behaviors of human glioblastome U118 MG cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2021, 47(3): 566-574.
[3]	Xining LI, Wei WENG, Zheyuan SHEN, Xiaojie DOU, Yu ZHAO, Jikang MIN. Effect of mTOR phosphorylation level on proliferation,autophagy，and differentiation of MC3T3-E1 osteoblasts and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2021, 47(3): 575-586.
[4]	Jia FENG, Haichan XU, Jian WEN, Zehua WU, Yi CHEN. Effect of betulinic acid on proliferation and apoptosis of myeloma cells by regulating JAK2/STAT3 signaling pathway and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2021, 47(3): 615-622.
[5]	Lei XIE, Xiaoli LIU, Jing GE, Yawei LI. Effects of baicalin combined with metformin on endocrine, inflammatory factors and insulin resistance in rats with polycystic ovary syndrome and their mechanisms [J]. Journal of Jilin University(Medicine Edition), 2021, 47(3): 623-629.
[6]	Bo MA, Jiangang LI, Jun WANG, Junli HOU, Liang LI. Promotion effect of miR-106b on invasion and migration of colon cancer cells through targeting TGF-β/Smad pathway [J]. Journal of Jilin University(Medicine Edition), 2021, 47(3): 630-636.
[7]	Xiaohui LI, Ziwei QU, Xin LU, Qingbin MENG, Huatao CHEN, Jun REN, Chengpei TAN. Regulatory effect of exosomes carrying miR-196b-5p derived from bone marrow mesenchymal stem cells on biological characteristics of colon cancer cells [J]. Journal of Jilin University(Medicine Edition), 2021, 47(3): 660-668.
[8]	Ying YANG, Wei ZHAO, Dan LYU. Effect of C19ORF12 on proliferation and chemo-sensitivity of gastric cancer MKN45 cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2021, 47(3): 687-693.
[9]	Zhangqi LOU,Qifan YU,Xuezhi SHEN,Hongqing CHEN,Yufeng LUO,Qianye CHEN,Guofen ZHENG,Yuemin DING,Xiong ZHANG. Effect of DEHP exposure in pregnant mice on neurobehavior of offsprings and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2021, 47(2): 323-329.
[10]	Haoxuan TANG,Nanfeng MENG,Meiling DU,Wei WANG,Tao HE. Inhibitory effect of new VEGF monoclonal antibody combined with all-trans retinoic acid on proliferation of breast cancer MCF-7 cells [J]. Journal of Jilin University(Medicine Edition), 2021, 47(2): 344-351.
[11]	Nuan WANG,Lijuan YANG,Juanjuan DAI,Aili WANG,Yan WU,Chengxia LIU. Promotion effects of MARCH1 on migration and invasion of human gastric cancer cells through PI3K/AKT signaling pathway [J]. Journal of Jilin University(Medicine Edition), 2021, 47(2): 352-359.
[12]	Jing WANG,Jing LIU,Xujing WEI,Yafei DU,Guiying FANG,Lin LI. Effects of oridonin on proliferation, migration, invasion and expression of lncRNA CCAT1 of endometrial carcinoma HEC-1B cells [J]. Journal of Jilin University(Medicine Edition), 2021, 47(2): 384-389.
[13]	Qi ZHAO,Changhai HE,Zhi WANG,Xuefeng WANG,Xiaofei LIU. Inhibitory effect of ALKBH3 knockdown on growth, migration and tumor angiogenesis of bladder cancer cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2021, 47(2): 397-406.
[14]	Chunying ZHANG,Guangwei YIN,Mingda YOU,Hong CHEN,Yaojie HU,Yanbing LI,Chunyou CHEN. Inhibitory effects of siRNA targeting silencing TAK1 gene on proliferation and migration of thyroid cancer cells and p38 MAPK signaling pathway [J]. Journal of Jilin University(Medicine Edition), 2021, 47(1): 110-117.
[15]	. Inhibitory effect of curcumin on tumor growth in colorectal cancer mice and its mechanism of PTEN/PI3K/Akt signaling pathwayPEI Yongbin， WANG Guiqi， LI Wei， JIANG Xia， JIANG Haibo， ZHAO Zengren （Department of General Surgery，First Hospital，Hebei Medical University， Shijiazhuang 050031，China） [J]. Journal of Jilin University(Medicine Edition), 2021, 47(1): 145-151.

Effect of metformin on proliferation of lung cancer A549 cells through PI3K/AKT/GSK3β signaling pathway

RichHTML

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 8

References

Related Articles 15

Metrics

Comments

Recommended 10